biotechtalk.net � Cell Genesys shares soar on positive GVAX prostate trial data (at MarketWatch): "Biotech Press - Biotechnology News
Cell Genesys shares soar on positive GVAX prostate trial data (at MarketWatch)
Shares of Cell Genesys Inc. rallied Monday, a move higher precipitated by positive research data for GVAX, the biotechnology company's prostate-cancer drug therapy."
